S2 14. Are the PMCPA acting like shouty (ignored) parents?
Trends from Q1 published PMCPA rulings show a staggering 96% allege poor standards - what does this mean and what can we do about this?
16 Touko 20243min
S2 E13 Bad v Good Signatories
Sarah Hollywood from HollywoodMedico chats to Jean about ' bad blocker' signatories and provides tips on how 'good' signatories can give teams the competitive edge.
9 Touko 20245min
S2 E12 Want to know how to make a complaint to the PMCPA?
Rubbish complaints cause confusing PMCPA rulings which lead to pharma's lack of clarity. Here are 5 top tips to lodge the "perfect" complaint to the PMCPA.
2 Touko 20245min
S2 E11 Patient Organisations: CLEAR declarations of pharma involvement can be UNCLEAR!
Patient Organisations often receive support from pharma companies BUT Case AUTH/3676/7/22 vs Roche helps us understand respective liabilities. Interested to learn the why, what and how? Come along to ...
25 Huhti 20243min
S2 E10 "A Tale of Two Clause 2s"
Three top tips from a good discussion about 2 cases and senior leader activities on social media - don't stop, challenge the PMCPA and appeals are worth it!! Case AUTH/3741/2/23 Case AUTH/3707/11/22
18 Huhti 20243min
S2 E9 Don't stop liking on SM (again!)
We discuss the results of a recent LinkedIn poll and the ruling for Pfizer which suggest employees should review their past social media engagements - but that does not mean STOP engaging!
11 Huhti 20243min
S2 E8. Sales reps calls: Define, differentiate and remind
How to reduce confusion, encourage good record-keeping and stay complaint when briefing reps about call rates.
4 Huhti 20243min
S2 E7: How to get a no breach for "game-changing" media articles!!
Sensational language, Mail article...yet no breach for GSK! Rina & Jean discuss why (Case AUTH/3691/9/22). A must listen for your comms team!
28 Maalis 20244min
